Perhaps your pharmacist mentioned that Semglee is now available as an alternative to Basaglar, or maybe your insurance switched coverage from one to the other, and now you’re wondering if these insulins are truly the same or if switching will affect your blood sugar control.
Here’s the short answer: Yes, Basaglar and Semglee are usually interchangeable for diabetes treatment. Both contain insulin glargine at the same concentration (100 units per milliliter). Semglee has FDA approval as an interchangeable biosimilar, which means pharmacists can substitute it for Basaglar without contacting your doctor, similar to how generic medications work.
Understanding what makes these insulins equivalent, what to expect when switching, and why one might be preferred over the other can help you feel confident about using either medication.
What Makes These Insulins the Same
Basaglar and Semglee both contain insulin glargine as their active ingredient. They’re both long-acting insulins designed to provide steady background insulin coverage for approximately 24 hours at the same U-100 concentration.
Semglee received FDA designation as an interchangeable biosimilar in 2021.
This designation means extensive testing proved that Semglee produces the same results when switched back and forth with other insulin glargine products. The interchangeable designation has practical implications – pharmacists can automatically substitute Semglee without getting permission from your doctor first.
Basaglar doesn’t have the formal interchangeable designation, though it’s been used successfully since 2015. In practice, both insulins work effectively for managing diabetes because they contain the same active ingredient at the same concentration.
How These Insulins Work
Both Basaglar and Semglee are long-acting insulins that help manage the glucose your liver naturally releases between meals and overnight. According to the Centers for Disease Control and Prevention, over 38 million Americans have diabetes, and many use long-acting insulin to keep fasting blood sugar stable.
You inject these insulins once daily at the same time each day.
Most people inject in the evening, though some doctors recommend morning injection depending on individual blood sugar patterns.
The insulin is absorbed slowly from the injection site, providing a relatively flat insulin level without significant peaks. This steady action reduces the risk of low blood sugar compared to older insulin formulations that had more pronounced activity curves.
Both insulins work through the same mechanism because they contain identical active ingredients. They bind to insulin receptors on cells throughout your body, allowing glucose to move from your bloodstream into cells where it’s used for energy.
Clinical Effectiveness
Basaglar and Semglee produce equivalent blood sugar control. Your A1C levels, fasting blood sugar, and overall glucose management should remain stable when switching between these insulins.
Basaglar has been available since 2015 and has extensive real-world use data showing it effectively controls blood sugar in people with both type 1 and type 2 diabetes.
Semglee has been available since 2020 and also has strong clinical evidence supporting its effectiveness.
Side effect profiles are essentially identical:
- Low blood sugar if doses are too high
- Injection site reactions like redness or irritation
- Weight gain as blood sugar comes under better control
- Allergic reactions, though these are rare
The risk of experiencing these side effects is the same whether you’re using Basaglar or Semglee.
Switching Between These Insulins
If you’re currently taking Basaglar and your pharmacy switches you to Semglee, or vice versa, you continue with the same dose. The insulins are dosed identically because they have the same concentration and work the same way.
Your doctor might recommend monitoring your blood sugar slightly more frequently for the first week or two after switching.
This precaution helps ensure the switch goes smoothly and your blood sugar remains stable.
Most people don’t notice any difference when switching between these insulins. Your blood sugar control, how you feel, and any side effects you experience should remain consistent.
If you do notice changes in your blood sugar patterns after switching, contact your doctor. Individual responses can vary, and small dose adjustments might be needed. This happens occasionally, even though the insulins are clinically equivalent.
When These Insulins Aren’t Interchangeable
While Basaglar and Semglee are generally interchangeable, a few situations require consideration.
If you’ve had an allergic reaction to one of these insulins, switching to the other may or may not be safe. Since both contain a similar active ingredient, allergic reactions to insulin glargine itself might occur with both products. But, if you’ve had a reaction to ingredients specific to one product, the other might be tolerable. Your doctor needs to evaluate this carefully.
Some doctors have strong preferences based on their clinical experience. If your doctor specifically prescribed one for a particular reason related to your situation, discuss with them before switching.
Injection Devices
Both Basaglar and Semglee come in prefilled pens designed for easy use. The pen devices differ in appearance and operation, but both are straightforward once you understand how they work.
Basaglar comes in the KwikPen. Semglee comes in its own prefilled pen design.
If you’re switching from one to the other, your pharmacist or doctor can show you how to use the new pen. The learning curve is minimal – most people adapt quickly.
The injection technique remains the same regardless of pen design:
- Clean the injection site with alcohol
- Pinch the skin and insert the needle at a 90-degree angle
- Inject the insulin slowly
- Count to 10 before removing the needle
- Rotate injection sites to prevent tissue buildup
Both insulins should be injected into fatty tissue under the skin, typically in your abdomen, thighs, or upper arms. Rotating between different injection sites helps prevent lipohypertrophy, which is a buildup of fatty tissue that can affect insulin absorption.
Storage Requirements
Basaglar and Semglee have identical storage requirements. Unopened pens should be refrigerated until you’re ready to use them. Once you start using a pen, you can keep it at room temperature for up to 28 days. Do not return it to the refrigerator, because once it’s open, it expires in 28 days regardless of how it’s stored.
Never freeze insulin.
Freezing destroys insulin’s effectiveness, making it unable to control blood sugar properly. If insulin freezes accidentally, discard it and use a new pen.
Protect insulin from extreme heat and direct sunlight. Don’t leave insulin in a hot car or near a window where the sun hits it directly. Heat degrades insulin just like freezing does.
Check your insulin before each injection. Both Basaglar and Semglee should be clear and colorless. If the insulin looks cloudy, discolored, or contains particles, don’t use it. These changes indicate the insulin has degraded.
Cost Differences
Cost often influences which insulin you use. The price difference between Basaglar and Semglee varies depending on your insurance coverage.
Some insurance plans prefer one over the other and place it on a lower tier with a smaller co-pay.
Your specific out-of-pocket cost depends on your insurance formulary, which is the list of medications your plan covers and how much each costs.
If your insurance switches from covering one to the other, this usually happens because they negotiated better pricing with one manufacturer. The switch shouldn’t affect your medical care since the insulins are equivalent, though it might change your copay amount.
Without insurance, both insulins are expensive. List prices run several hundred dollars per month. Patient assistance programs exist for both Basaglar and Semglee and can significantly reduce costs for people who qualify based on income and insurance status.
Why Your Pharmacy Might Switch
Pharmacies sometimes switch between Basaglar and Semglee based on which one your insurance covers or which manufacturer they have supply agreements with. Because Semglee has an interchangeable designation, pharmacies can make this substitution automatically.
Insurance formulary changes happen regularly.
Insurance companies negotiate with drug manufacturers for better pricing, and these negotiations can result in one being preferred over another.
Supply issues occasionally affect insulin availability. If one manufacturer experiences production problems, pharmacies might switch patients to the alternative to ensure continuous insulin access.
These switches are medically appropriate because the insulins are equivalent. The main impact on you is learning to use a different pen device if the design differs from what you’re used to.
When to Contact Your Doctor
Most people switch between Basaglar and Semglee without problems. Contact your doctor if you experience:
- Significant changes in blood sugar patterns persisting more than a few days
- More frequent low blood sugar episodes
- Higher fasting blood sugar readings than usual
- Unusual injection site reactions
- Any new symptoms that concern you
These situations are uncommon when switching between equivalent insulins, but individual responses can vary.
What Your Doctor Might Prefer
Even though these insulins are interchangeable, your doctor might have reasons to prefer one for your specific situation.
Some doctors have more experience with one product and feel more comfortable managing patients on that insulin. Clinical experience matters, and if your doctor has successfully managed many patients on Basaglar, they might continue prescribing it.
If you’ve been stable on one of these insulins for a long time, your doctor might prefer you stay on it rather than switch unnecessarily.
Stability in diabetes management has real value.
Cost considerations might lead your doctor to prescribe whichever insulin your insurance covers more favorably. Ensuring you can afford your insulin matters more than differences between equivalent products.
Making Your Decision
Basaglar and Semglee are clinically equivalent insulins that work the same way and produce the same results. Semglee’s FDA designation as interchangeable confirms that switching between these insulins is safe and effective.
If your pharmacy or insurance switches you from one to the other, you can feel confident using either medication.
Continue with the same dose, use proper injection technique, and monitor your blood sugar as recommended by your doctor.
Cost differences between these insulins depend on your insurance coverage. Both are good options for managing diabetes, and having two equivalent options helps keep insulin more affordable and accessible.
Diabetes management is challenging enough without worrying about affording your insulin. If you’re struggling with costs for Basaglar, Semglee, or any other diabetes medication, The Rx Advocates wants to help. We work with patient assistance programs to connect you with insulin at reduced or no cost based on your eligibility. Contact us online or call us at (844) 559-8331 today to find out if you qualify for programs that can make your insulin affordable.